News | May 11, 2024
Piramal Pharma posts Q1 FY24 consolidated PAT at Rs. 101.27 Cr
Piramal Pharma has reported total income of Rs. 2,578.74 crores during the period ended March 31, 2024
Piramal Pharma has reported total income of Rs. 2,578.74 crores during the period ended March 31, 2024
Neuland Laboratories has reported total income of Rs. 390.36 crores during the period ended March 31, 2024
The company has posted net profit of Rs.118.82 crores for the Financial Year ended March 31, 2024
The company has posted net profit of Rs.171.42 crores for the Financial Year ended March 31, 2024
The company has posted net loss of Rs. 105.07 crores for the Financial Year ended March 31, 2024
The company has reported total income of Rs. 155.79 crores during the period ended March 31, 2024
The company has reported total income of Rs. 2,943.49 crores during the period ended March 31, 2024
The company has reported total income of Rs. 1,089.58 crores during the period ended March 31, 2024
Laurus Labs has reported total income of Rs. 1,458.20 crores during the period ended March 31, 2024
Syngene International has reported total income of Rs. 933 crores during the period ended March 31, 2024
Subscribe To Our Newsletter & Stay Updated
